Iron: A Pathological Mediator of Alzheimer Disease?
- 1 October 2002
- journal article
- review article
- Published by S. Karger AG in Developmental Neuroscience
- Vol. 24 (2-3), 184-187
- https://doi.org/10.1159/000065696
Abstract
Brains from patients with Alzheimer disease (AD) show a disruption in the metabolism of iron, such that there is an accumulation of iron in senile plaques, and an altered distribution of iron transport and storage proteins. One of the earliest events in AD is the generation of oxidative stress, which may be related to the generation of free radicals by the excess iron that is observed in the disease. Iron has also been shown to mediate the in vitro toxicity of amyloid-β peptide, and the presence of iron in most in vitro systems could underlie the toxicity that is normally attributed to amyloid-β in these studies. In contrast, several recent studies have suggested that amyloid-β may decrease oxidative stress and decrease the toxicity of iron. Continued examination of the complex interactions that occur between iron and amyloid-β may assist in the elucidation of the mechanisms that underlie the neurodegeneration that leads to dementia in AD.Keywords
This publication has 19 references indexed in Scilit:
- The relationship between the aggregational state of the amyloid‐β peptides and free radical generation by the peptidesJournal of Neurochemistry, 2001
- New evidence that the Alzheimer β-amyloid peptide does not spontaneously form free radicals: An ESR study using a series of spin-trapsFree Radical Biology & Medicine, 2001
- Redox-active iron mediates amyloid-β toxicityFree Radical Biology & Medicine, 2001
- Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasmaFree Radical Biology & Medicine, 2001
- Characterization of Copper Interactions with Alzheimer Amyloid β PeptidesJournal of Neurochemistry, 2000
- In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s DiseaseJournal of Neurochemistry, 2000
- Binding of Zn(II), Cu(II), and Fe(II) ions to alzheimer's Aß peptide studied by fluorescenceBioorganic & Medicinal Chemistry Letters, 1999
- Cytotoxicity of advanced glycation endproducts is mediated by oxidative stressJournal of Neural Transmission, 1998
- The Role of Iron in Beta Amyloid ToxicityBiochemical and Biophysical Research Communications, 1995
- β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s DiseaseBiochemical and Biophysical Research Communications, 1994